← Open Payments lookup

LINDY LAY: Open Payments

NPI 1285074559 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,281 in 58 payments from 9 companies in 2025. Trend: 2023 $1,149 · 2024 $1,125 · 2025 $1,281

Food & beverage: $1,281
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$313
Neurocrine BioSciences, Inc.12$255
E.R. Squibb & Sons, L.L.C.11$220
Alkermes, Inc.8$214
Teva Pharmaceuticals USA, Inc.5$98
ABBVIE INC.5$94
Takeda Pharmaceuticals U.S.A., Inc.2$36
Janssen Pharmaceuticals, Inc1$31
Axsome Therapeutics, Inc.1$21

Products named: CAPLYTA, INGREZZA, COBENFY, ARISTADA, VRAYLAR, AUSTEDO XR, TRINTELLIX, SPRAVATO.

Industry payments across CA — which companies pay providers there.